These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37109332)

  • 1. Heart Valve Involvement in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Study of a Single Centre.
    Pons I; Louro J; Sitges M; Vidal B; Cervera R; Espinosa G
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valvular heart disease in patients with anti-phospholipid syndrome].
    Muñoz-Rodríguez FJ; Reverter Calatayud JC; Font Franco J; Espinosa Garriga G; Tàssies Penella D; Ingelmo Morin M
    Rev Clin Esp; 2002 Oct; 202(10):529-33. PubMed ID: 12361550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
    Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
    Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Libman-Sacks endocarditis complicating antiphospholipid syndrome: a retrospective analysis of 23 operated cases.
    Chalvon NB; Costedoat-Chalumeau N; Pennaforte JL; Servettaz A; Boulagnon Rombi C; Gavand PE; Lekieffre M; Le Guern V; Morel N; Cohen Aubart F; Haroche J; Mathian A; Collet JP; Piette JC; Amoura Z; Orquevaux P
    Rheumatology (Oxford); 2023 Feb; 62(2):707-715. PubMed ID: 35686908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: a 10-year follow-up study.
    Kampolis C; Tektonidou M; Moyssakis I; Tzelepis GE; Moutsopoulos H; Vlachoyiannopoulos PG
    Semin Arthritis Rheum; 2014 Feb; 43(4):558-65. PubMed ID: 24012042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
    Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
    J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.
    Hojnik M; George J; Ziporen L; Shoenfeld Y
    Circulation; 1996 Apr; 93(8):1579-87. PubMed ID: 8608627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus].
    Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL
    Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
    Islabão AG; Mota LMH; Ribeiro MCM; Arabi TM; Cividatti GN; Queiroz LB; Andrade DC; Sakamoto AP; Trindade VC; Novak GV; Molinari BC; Campos LM; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Marini R; Gomes HR; Silva MF; Oliveira SK; Sztajnbok FR; Sacchetti SB; Bica BE; Sena EG; Moraes AP; Santos MC; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Naka EN; Guimarães LJ; Santos FP; Sampaio MC; Bonfá E; Silva CA;
    Autoimmun Rev; 2020 Dec; 19(12):102693. PubMed ID: 33164791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to types I and IV collagen and heart valve disease in systemic lupus erythematosus/antiphospholipid syndrome.
    Pardos-Gea J; Cortés-Hernández J; Castro-Marrero J; Balada E; Ordi-Ros J
    Clin Rheumatol; 2017 Jun; 36(6):1401-1406. PubMed ID: 28283766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features associated with epilepsy in the antiphospholipid syndrome.
    Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
    J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome.
    Cieśla M; Wypasek E; Undas A
    Adv Clin Exp Med; 2014; 23(5):729-33. PubMed ID: 25491686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies.
    Roldan CA; Shively BK; Lau CC; Gurule FT; Smith EA; Crawford MH
    J Am Coll Cardiol; 1992 Nov; 20(5):1127-34. PubMed ID: 1341885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range].
    Seredavkina NV; Reshetnyak TM; Satybaldyeva MA; Kashnikova LN; Temnikova TA; Nasonov EL
    Ter Arkh; 2019 May; 91(5):19-25. PubMed ID: 32598672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.